Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.

The American journal of surgical pathology - 1 Mar 2015

Chisholm Karen M, Bangs Charles D, Bacchi Carlos E, Molina-Kirsch Hernan, Cherry Athena, Natkunam Yasodha

Abstract excerpt

MYC translocations are a defining feature of Burkitt lymphoma and a group of diffuse large B-cell lymphoma (DLBCL) with inferior outcome. However, the clinical relevance of MYC gene rearrangement and its relationship with MYC protein expression has not been well characterized in lymphomas. Tissue microarrays containing 1214 lymphomas were successfully evaluated by immunohistochemistry using anti-MYC clone Y69 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnosis, Differential
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Rearrangement

Share to In Situ Hybridization, Fluorescence

Share to Lymphoma

Share to Predictive Value of Tests

Share to Proto-Oncogene Proteins c-myc

Share to Tissue Array Analysis

Source

Identifiers

PMID: 25581730
DOI: 10.1097/PAS.0000000000000365

Genes

MYC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.PMID 25581730Read ↗

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapySemantic proximity Read ↗

Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classificationSemantic proximity Read ↗

MYC and Aggressive B-cell LymphomasSemantic proximity Read ↗

MYC‐associated and double‐hit lymphomas: A review of pathobiology, prognosis, and therapeutic approachesSemantic proximity Read ↗

MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.Semantic proximity Read ↗

Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell LymphomasSemantic proximity Read ↗

Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomasSemantic proximity Read ↗

MYC alterations in diffuse large B-cell lymphomas.Semantic proximity Read ↗

MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical managementSemantic proximity Read ↗

Burkitt Lymphoma and MYCSemantic proximity Read ↗

MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes.Semantic proximity Read ↗

Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potentialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.